Cibinqo vs. Dupixent Saxenda vs. Wegovy Skyrizi vs. Stelara Cosentyx vs. Taltz Tosymra vs. Emgality Ajovy vs. Nurtec ODT Xarelto vs. Eliquis Opdivo vs. Keytruda Kisqali vs. Ibrance Xtandi vs. Erleada Praluent vs. Repatha Cibinqo vs. Opzelura Ilumya vs. Taltz Kisunla vs. Leqembi View all Comparisons

ADHD drugs Anxiety drugs Asthma drugs Atopic dermatitis drugs Depression drugs Heart failure drugs Hypertension drugs Lymphoma drugs Osteoarthritis drugs Rheumatoid arthritis drugs Rosacea drugs Schizophrenia drugs Type 2 Diabetes drugs View all Indications

Bayer drugs AbbVie drugs AstraZeneca drugs Eli Lilly and Company drugs Genetech drugs GlaxoSmithKline (GSK) drugs Novartis drugs Pfizer drugs Takeda Pharmaceuticals drugs Teva Pharmaceuticals drugs Amgen drugs View all Manufacturers

Beta-Adrenergic Blocker Angiotensin Converting Enzyme Inhibitor Angiotensin 2 Receptor Blocker Calcium Channel Blocker Diuretics HMG-CoA Reductase Inhibitor Proton Pump Inhibitor Selective Serotonin Reuptake Inhibitor Norepinephrine Reuptake Inhibitor Benzodiazepines Opioid Agonists Nonsteroidal Anti-inflammatory Drugs Antiepileptic Agents Antipsychotics Antihistamines View all Classes

Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®

HIPAA COMPLIANT

Soc 2 Type II

HIPAA COMPLIANT

Soc 2 Type II

For ProvidersRequest Demo Join Research Panel

Prescribing toolsPrescribing Info Coverage Savings A-Z Indications Compare Drugs

CompanyAbout Careers Contact Us Security

Get the latest insights in your inbox

Terms and Conditions

© 2026 PrescriberPoint. All Rights Reserved.

View All Medications for Acute hyperammonemia

Home
Indications
Acute Hyperammonemia

Medications for Acute Hyperammonemia

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

2 results

carbaglu
(Carglumic Acid)
Medication Details
Recordati Rare Diseases
Usage: CARBAGLU is indicated for adult and pediatric patients as adjunctive therapy and maintenance treatment for acute and chronic hyperammonemia due to N-acetylglutamate Synthase (NAGS) deficiency, as well as adjunctive therapy for acute hyperammonemia caused by Propionic Acidemia or Methylmalonic Acidemia.
Medication Details
sodium phenylbutyrate - sodium phenylbutyrate powder
(Sodium Phenylbutyrate)
Medication Details
Endo Usa, Inc.
Usage: Sodium phenylbutyrate powder is indicated as adjunctive therapy for chronic management of urea cycle disorders, including neonatal-onset and late-onset deficiencies. It is used to lower ammonia levels in patients, especially those with a history of hyperammonemic encephalopathy, in conjunction with dietary protein restriction.
Medication Details
Drug Interactions